Nov 07, 2023 / 06:00AM GMT
Presentation
Nov 07, 2023 / 06:00AM GMT
=====================
Corporate Participants
=====================
* Akiko Nakahama
Eisai Co., Ltd. - VP and Chief Portfolio Off. of Japan, Asia Filing & Regi. and Chief Qult. Off. of Japan Reg. Affairs
* Haruo Naito
Eisai Co., Ltd. - CEO, Representative Corporate Officer & Director
* Lynn D. Kramer
Eisai Co., Ltd. - VP & Chief Clinical Officer - Alzheimer's Disease and Brain Health
* Masatomi Akana
Eisai Co., Ltd. - Chief Gov. Rel. and IR Officer, SVP of Global Value, Acc., Japan Subs, General, Env. & Safety Aff.
* Satoru Yasuda
* Yasunobu Kai
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
UBS Investment Bank, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc. Exchange Research - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Miki Sogi
Sanford C. Bernstein & Co., LLC
Eisai Co Ltd
(OTCPK:ESALF)
$
33.97
0.97 (2.94%)
Market Cap: 9.57 Bil
Enterprise Value: 8.56 Bil
PE Ratio: 41.33
PB Ratio: 1.65
GF Score: 70/100 Q2 2024 Eisai Co Ltd Earnings Presentation Transcript
Nov 07, 2023 / 06:00AM GMT
Release Date Price:
$52.71
(-0.57%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot